Denali Therapeutics DNLI
NASDAQ DNLI
$20.67 -0.14 (-0.67%)
At close: Sep 30, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Shares Outstanding (Entity) (2017 - 2026)

Updated

Denali Therapeutics (DNLI) reported Shares Outstanding (Entity) of 159.76 million for Q2 2026, up 9.7% from 145.69 million a year earlier and up 0.7% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends

For FY2025, Denali Therapeutics posted Shares Outstanding (Entity) of 156.18 million, up 8.3% from FY2024.

  • Shares Outstanding (Entity) has increased for nine consecutive years, with a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
  • By year, Shares Outstanding (Entity) came in at 144.22 million in FY2024 (+4.2%), 138.39 million in FY2023 (+1.8%), 135.97 million in FY2022 (+11.2%) and 122.28 million in FY2021 (+1.5%).
  • The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2017.
  • Year over year, Shares Outstanding (Entity) has now increased in each of the last 34 quarters, with growth averaging 5.2% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.3% in Q2 2022 to 11.5% in Q2 2023.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 158.66 million (Q1 2026), 156.18 million (Q4 2025) and 146.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Denali Therapeutics 3.30 Bn 3.30 Bn 3.51 Mn 159.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 159.76 Mn
Mar 31, 2026 158.66 Mn
Dec 31, 2025 156.18 Mn
Sep 30, 2025 146.63 Mn
Jun 30, 2025 145.69 Mn
Mar 31, 2025 145.25 Mn
Dec 31, 2024 144.22 Mn
Sep 30, 2024 143.84 Mn
Jun 30, 2024 143.12 Mn
Mar 31, 2024 142.51 Mn
Dec 31, 2023 138.39 Mn
Sep 30, 2023 138.05 Mn
Jun 30, 2023 137.36 Mn
Mar 31, 2023 136.74 Mn
Dec 31, 2022 135.97 Mn
Sep 30, 2022 123.80 Mn
Jun 30, 2022 123.16 Mn
Mar 31, 2022 122.86 Mn
Dec 31, 2021 122.28 Mn
Sep 30, 2021 122.01 Mn
API Access

Denali Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=DNLI&period=max&api_key=YOUR_API_KEY